New human cell line as a tool for therapy development in renal cancer
2016
University of Foggia, Foggia, Italy
Renal cell carcinoma (RCC) is the most common kidney cancer. In this study, the researchers established one new cell line from one RCC patient and characterized it by genomics, proteomics and immunological analysis. The novel established immunogenic cell line will be suitable for immune stimulation. The identification of novel tumour-associated antigens will allow the evaluation of the immune response in vitro and, subsequently, in vivo paving the way for new immunotherapeutic strategies in the RCC setting.
Establishment and characterization of a highly immunogenic human renal carcinoma cell line
Elena Ranieri
Added on: 07-27-2021
[1] https://www.spandidos-publications.com/10.3892/ijo.2016.3544[2] https://data.jrc.ec.europa.eu/dataset/352f7dfd-05cf-434b-a96a-7e270dc76573
